PAP
EVH icon

Persistent Asset Partners’s Evolent Health EVH Stock Holding History

Persistent Asset Partners’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-77,638
Closed -$657K – 390
2025
Q3 		$657K Sell
77,638
-78,091
-50% -$758K 0.45% 72
2025
Q2 		$1.75M Buy
+155,729
New +$1.43M 1.3% 21

Other funds holding EVH

CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Persistent Asset Partners's EVH Position: Q4 2025 in Review

Persistent Asset Partners sold out of Evolent Health (EVH) in Q4 2025, closing a stake of 77,638 shares — an estimated $657K sold.

Persistent Asset Partners first reported a position in EVH in Q2 2025 and held it in 2 quarters. The position peaked at $1.75M in Q2 2025. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.

  • Persistent Asset Partners reported no remaining Evolent Health position as of Q4 2025 after selling out during the quarter.
  • Persistent Asset Partners sold 77,638 Evolent Health shares in Q4 2025, an estimated $657K.
  • Persistent Asset Partners first reported a position in Evolent Health in Q2 2025 and held it in 2 quarters.
  • Persistent Asset Partners's Evolent Health position peaked at $1.75M in Q2 2025.
  • 215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.

Based on Persistent Asset Partners's 13F filing for Q4 2025, filed 17 Feb 2026.